drugset / Trial / NCT00955318
Long-Term Safety Study of KW-6500 in Patients With Parkinson's Disease
NaSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to evaluate the safety and efficacy of KW-6500 when administered as long-term subcutaneous self-injections in Parkinson's disease patients with motor response complications on levodopa therapy.
Timeline
- Start
- 2009-07
- Primary completion
- 2010-12
- Completion
- 2012-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Apomorphine | Unknown | 1 mg | Subcutaneous |
| Subject | Apomorphine | Unknown | 6 mg | Subcutaneous |